Li, H.; Yang, A.; Zhao, S.; Chow, E.Y.; Javanbakht, M.; Li, Y.; Lin, D.; Xu, L.; Zang, D.; Wang, K.;
et al. Continuous Subcutaneous Insulin Infusion (CSII) Combined with Oral Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis of Randomized, Controlled Trials. Pharmaceuticals 2022, 15, 953.
https://doi.org/10.3390/ph15080953
AMA Style
Li H, Yang A, Zhao S, Chow EY, Javanbakht M, Li Y, Lin D, Xu L, Zang D, Wang K,
et al. Continuous Subcutaneous Insulin Infusion (CSII) Combined with Oral Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis of Randomized, Controlled Trials. Pharmaceuticals. 2022; 15(8):953.
https://doi.org/10.3390/ph15080953
Chicago/Turabian Style
Li, Hui, Aimin Yang, Shi Zhao, Elaine YK Chow, Mohammad Javanbakht, Yinhui Li, Dandan Lin, Lijuan Xu, Deng Zang, Kai Wang,
and et al. 2022. "Continuous Subcutaneous Insulin Infusion (CSII) Combined with Oral Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis of Randomized, Controlled Trials" Pharmaceuticals 15, no. 8: 953.
https://doi.org/10.3390/ph15080953
APA Style
Li, H., Yang, A., Zhao, S., Chow, E. Y., Javanbakht, M., Li, Y., Lin, D., Xu, L., Zang, D., Wang, K., & Ma, L.
(2022). Continuous Subcutaneous Insulin Infusion (CSII) Combined with Oral Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis of Randomized, Controlled Trials. Pharmaceuticals, 15(8), 953.
https://doi.org/10.3390/ph15080953